CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Crane Rosemary A Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2024-06-13 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2024-06-13 | YARNO WENDY L Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2024-06-13 | Lin Elizabeth Yeu Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2024-06-13 | Lin Elizabeth Yeu Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2024-06-13 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2024-06-13 | Morrison Scott W Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2024-06-13 | LINK WILLIAM J PHD Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2024-06-13 | LINK WILLIAM J PHD Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2024-03-18 | Mottiwala Aziz Chief Commercial Officer | Sale | −4,766 | $30.60 | $146K | 54,075 |
| 2024-03-18 | Wahl Bryan General Counsel | Sale | −4,436 | $30.60 | $136K | 40,951 |
| 2024-03-18 | Azamian Bobak R. President/CEO and Board Chair | Sale | −10,415 | $30.60 | $319K | 26,456 |
| 2024-03-18 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −4,314 | $30.60 | $132K | 34,181 |
| 2024-03-18 | Neervannan Seshadri Chief Operating Officer | Sale | −4,879 | $30.60 | $149K | 64,767 |
| 2024-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion | +12,938 | 58,841 | ||
| 2024-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −4,790 | 9,580 | ||
| 2024-03-15 | Mottiwala Aziz Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −8,148 | 24,444 | ||
| 2024-03-15 | Wahl Bryan General Counsel | Exercise or conversion | +12,038 | 45,387 | ||
| 2024-03-15 | Wahl Bryan General Counsel | Exercise or conversion · Restricted Stock Units | −4,790 | 9,580 | ||
| 2024-03-15 | Wahl Bryan General Counsel | Exercise or conversion · Restricted Stock Units | −7,248 | 21,745 |
Page 15 of 24 · 469 trades